Therapeutic Antibody Integrated ADC discovery strategy and antibody/protein cell line development expertise sharing 03-02-2023 / Dr. Li Chen, Director of Biologics Discovery Dept., ProBio Integrated ADC discovery strategy and antibody/protein cell line development expertise sharing Learn More
Therapeutic Antibody Don’t miss ProBio and GlyTherix Live Webinar on 6th December 12-06-2022 / Brad Walsh, Chief Executive Officer, GlyTherix Ltd Don’t miss ProBio and GlyTherix Live Webinar on 6th December Learn More
Therapeutic Antibody IND-enabling CMC Strategies for Bispecific Antibodies 12-06-2022 / Rubin Jiang & Ian Chan IND-enabling CMC Strategies for Bispecific Antibodies Learn More
Therapeutic Antibody Take the Accelerated Path Upstream with IND Compliant CHOK1-GenS Cell Line Development 06-28-2022 / Ying Li, Director of Downstream Process Development, ProBio Learn More
Therapeutic Antibody Development of cell-based functional assay with high efficiency 02-04-2021 / Lihao Wang, Senior Scientist of In Vitro Bioassay, ProBio Learn More
Therapeutic Antibody Practical issues and strategies of biological product technology transfer 02-04-2021 / Aipeng Deng, Senior Scientist of MAST, ProBio Learn More
Therapeutic Antibody Robust Stable Cell Line Platform for Biologics Development 02-04-2021 / Hongxing Shi, Associate Director of Process Development, ProBio Learn More
Therapeutic Antibody Anti-idiotype Antibody Generation and Application in Antibody Drug Discovery 01-07-2021 / Alex Chen Are you developing antibody drugs? Have you considered generating anti-idiotype antibodies (anti-IDs)? Anti-IDs recognize the region unique to your antibody drug, the complementarity determining region (CDR) Learn More